{
    "2018-09-25": [
        [
            {
                "time": "2018-01-02",
                "original_text": "AKCA Up 33% In 2 Days, AGTC Awaits XLRS Data, EYPT On Watch",
                "features": {
                    "keywords": [
                        "AKCA",
                        "up",
                        "33%",
                        "AGTC",
                        "XLRS",
                        "EYPT"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotech",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "AstraZeneca's Imfinzi Gets EU Nod for Early-Stage Lung Cancer",
                "features": {
                    "keywords": [
                        "AstraZeneca",
                        "Imfinzi",
                        "EU",
                        "nod",
                        "lung cancer"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "USMV, PFE, WM, ACN: Large Inflows Detected at ETF",
                "features": {
                    "keywords": [
                        "USMV",
                        "PFE",
                        "WM",
                        "ACN",
                        "ETF",
                        "inflows"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance",
                        "ETFs"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Allergan’s First Medical Aesthetics Innovation Center in China",
                "features": {
                    "keywords": [
                        "Allergan",
                        "medical aesthetics",
                        "innovation center",
                        "China"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "cosmetics"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "AstraZeneca's Imfinzi Gets EU Nod for Early-Stage Lung Cancer",
                "features": {
                    "keywords": [
                        "AstraZeneca",
                        "Imfinzi",
                        "EU",
                        "nod",
                        "lung cancer"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "J&J Files for US Approval of Cancer Drug Erdafitinib",
                "features": {
                    "keywords": [
                        "J&J",
                        "US",
                        "approval",
                        "cancer drug",
                        "Erdafitinib"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Factors of Influence in 2018, Key Indicators and Opportunity within Dorchester Minerals, Teladoc, Pfizer, Intercontinental Exchange, General Electric, and Prospect Capital — New Research Emphasizes Economic Growth",
                "features": {
                    "keywords": [
                        "Dorchester Minerals",
                        "Teladoc",
                        "Pfizer",
                        "Intercontinental Exchange",
                        "General Electric",
                        "Prospect Capital",
                        "economic growth"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "energy",
                        "healthcare",
                        "finance",
                        "industrials"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Asian Shares Mixed As Investors Weigh Risks",
                "features": {
                    "keywords": [
                        "Asian shares",
                        "mixed",
                        "investors",
                        "weigh risks"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "global markets",
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}